Nicholas Holdgate, MD
Rheumatology · Summerville, SCNPI 1134415110
Payments from drug & device makers
Across 649 payments — averaging $821.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$417K
- Biogen$63K
- AbbVie$22K
- GSK$22K
- Johnson & Johnson$2K
- Novartis$1000
- plus $6K from 22 others
Across 3 payments — averaging $468.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 117 | $416,869 |
| Biogen | 5 | $62,953 |
| AbbVie | 135 | $22,415 |
| GSK | 28 | $22,412 |
| Johnson & Johnson | 81 | $1,695 |
| Novartis | 52 | $1,000 |
| UCB, Inc. | 51 | $935 |
| Lilly USA, LLC | 40 | $798 |
| Octapharma USA, Inc. | 4 | $713 |
| E.r. Squibb & Sons, L.L.C. | 41 | $710 |
| Eli Lilly | 1 | $652 |
| AstraZeneca(2 entities) | 23 | $438 |
| Pfizer | 27 | $421 |
| Organon | 7 | $161 |
| Aurinia Pharma U.S., Inc. | 6 | $148 |
| Regeneron Healthcare Solutions, Inc. | 6 | $136 |
| Genentech USA, Inc. | 5 | $94 |
| Fresenius Kabi USA, LLC | 4 | $87 |
| Boehringer Ingelheim | 4 | $79 |
| Radius Health, Inc. | 3 | $65 |
| ANI Pharmaceuticals, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Sobi, Inc | 1 | $26 |
| Sanofi | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Sandoz | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $14 |
How this compares
$532,975 in reported general payments places this provider in the 90th percentile of 123 rheumatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Summerville
- Clarence LegertonSummerville$7.7M
- Gary FinkSummerville$6.9M
- William EdwardsSummerville$5.9M
- Colin EdgertonSummerville$4.6M
- Gregory NiemerSummerville$4.4M
- Jennifer MurphySummerville$4.4M
- Richard SilverCharleston$1.6M
- Alan BrownGreenville$947K
- Mitchell FeinmanOrangeburg$824K
- Richard KimGreenville$706K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.